Coalition urges reformation of EU-wide drug research and development to drive treatment optimisation

Boost for patients with life-threatening conditions who require access to medicines not yet authorised for marketing

Updated Date: Tue, 25 Jan 2022 00:00:00 EST

Updated Date: Tue, 25 Jan 2022 00:00:00 EST

Updated Date: Tue, 25 Jan 2022 00:00:00 EST

Updated Date: Tue, 25 Jan 2022 00:00:00 EST

Updated Date: Tue, 25 Jan 2022 00:00:00 EST

Yesterday saw the publication of the Lancet Commission on the Value of Death: Bringing Death Back Into Life.1 […]

We went to the cinema last week. Hardly something to write about. But this was different. It was […]

How did UCB close its $1.9 billion deal to buy Zogenix and its key epilepsy drug? SEC filing […]